Pulmonary antibody mediated rejection (AMR) after lung transplantation is an
important cause of acute and chronic allograft dysfunction. It is critical that the lung
transplant clinician, pathologist and immunologist have a strong understanding of the
criteria for the diagnosis and assessment of AMR and of the approaches used to
manage these patients. Understanding the clinical, pathological and immunological
features of AMR will help to close the practice gap in specialist knowledge. We are
delighted to offer for the second time this interactive educational opportunity to
update the knowledge in this complex diagnostic scenario.
The interactive symposium is aimed at experienced lung transplant specialists
(Pulmonologists/Respirologists, Surgeons, Pathologists, Immunologists) that should
routinely work in a multidisciplinary team for a more sensitive and accurate diagnosis
and appropriate management of this complication.

Pulmonary antibody mediated rejection (AMR) after lung transplantation is an
important cause of acute and chronic allograft dysfunction. It is critical that the lung
transplant clinician, pathologist and immunologist have a strong understanding of the
criteria for the diagnosis and assessment of AMR and of the approaches used to
manage these patients. Understanding the clinical, pathological and immunological
features of AMR will help to close the practice gap in specialist knowledge. We are
delighted to offer for the second time this interactive educational opportunity to
update the knowledge in this complex diagnostic scenario.
The interactive symposium is aimed at experienced lung transplant specialists
(Pulmonologists/Respirologists, Surgeons, Pathologists, Immunologists) that should
routinely work in a multidisciplinary team for a more sensitive and accurate diagnosis
and appropriate management of this complication.

The 4th International Conference on End Stage Lung Diseases (ESLDs) will take place
in digital form, on October 27th, November 3rd and 10th, 2020.
Based on the success of the previous editions, the scientific organizing committee is
excited to launch its 4th theme-based scientific conference.
The ESLD conference is a forum of national and international experts who aim to share
experiences and outline best management for patients. The ESLDs focus on
progressive lung diseases potentially requiring lung transplantation and this year the
main theme will be Cystic Fibrosis (CF).
The efforts of all transplant specialists are directed towards the improvement of the
very complex transplant management of these usually young patients.
The novelty of this edition is not only a wide involvement of all the specialists
(psychologists, endocrinologists, pneumologists, surgeons, pathologists,
immunologists) who play a crucial role in the diagnostic/therapeutic process, but also
the participation of patient and family associations.